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MICROENCAPSULATION OF DRONEDARONE 
HYDROCHLORIDE BY SPRAY DRYING ORIGINAL SCIENTIFIC PAPER 











Microencapsulation is a method often used in various industries and one of the many advantages is that con-
trolled release of the active ingredient can be achieved. The aim of this study was to prepare microcapsules by 
spray drying by changing the process conditions and ratios of the used components, polymer excipient poly(vinyl 
alcohol) and active ingredient dronedarone hydrochloride. Dosage forms of poly(vinyl alcohol) and dronedarone 
hydrochloride were prepared in 1:1, 2:1 and 3:1 weight ratios and the solutions were dried in a laboratory spray 
dryer at four different atomization flowrates. The morphology of the obtained microcapsules was examined using 
a scanning electron microscope (SEM). The release kinetics of the active ingredient from the microcapsules were 
examined by in vitro laboratory testing and the resulting release profiles were described using the Weibull model. 
The results showed that the change of weight ratio has influence on the morphology of microcapsules, the effi-
ciency of microencapsulation and drug release. 
 




 In the pharmaceutical industry, coating processes 
of active ingredients are increasingly used to obtain 
controlled and prolonged drug release. A well-
designed, controlled release drug delivery system can 
overcome some of the problems of conventional de-
livery of the active ingredient and improve the thera-
peutic efficacy of a given drug [1]. One of the meth-
ods that enables the delivery of the active ingredient 
to the targeted location is microencapsulation [2]. 
Microencapsulation is a process where very tiny 
droplets or particles of liquid or solid material are 
surrounded or coated with a continuous film of pol-
ymeric material [3]. The primary reasons for micro-
encapsulation are controlled drug release, improve-
ment of the physical and chemical properties of the 
dosage form, protection of the active ingredient, 
masking of bad taste masking and easier handling of 
the dosage form [4]. An important step in microen-
capsulation process is selection of the polymer mate-
rial for coating of the active ingredient. When choos-
ing a polymer, it is important to pay attention to the 
following characteristics: polymer biodegradability, 
physical, chemical and thermal properties of poly-
mer, compatibility between the polymer and active 
ingredient, etc. [5]. There are many different methods 
of microencapsulation and the most commonly used 
method is spray drying. Spray drying is a method of 
drying liquid and semi-liquid solutions, suspensions, 
emulsions and droplets, in just one production step. 
The principle of spray drying is to disperse the drug 
solution into very small droplets in the atomizer. Sol-
vent rapidly evaporates in hot dry media to obtain a 
dry product in powder or granular form. In this pro-
cess, a product with a high degree of purity and a 
narrow particle size distribution is produced [6]. The 
aim of this work was to prepare prolonged release 
dosage form. Dronedarone hydrochloride (DNR) was 
used as the active ingredient and poly(vinyl alcohol) 
(PVA) was used as a polymer for the coating of the 
active ingredient. Microencapsulation was performed 
in a spray dryer and the release kinetic of droneda-
rone hydrochloride was studied by in vitro laboratory 
testing. 
 
MATERIALS AND METHODS 
MATERIALS 
 Antiarrhythmic drug, dronedarone hydrochloride, 
used in the experiments is received from TAPI Pilot, 
PLIVA Croatia Ltd. Dronedarone hydrochloride 
(DNR) is fine white crystalline powder, with melting 
point in range of 149 – 153°C [7]. Particle size of 
used DNR,  expressed with as x90, is 39.92 µm [8]. 
Poly(vinyl alcohol) (Acros Organic) with average 
molecule weight of 50000 – 85000 g mol
-1
 was used 
for microencapsulation. 
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PREPARATION OF MICROCAPSULES 
 Solutions with a different weight ratio of DNR 
and PVA (Table 1) were prepared for the spray dry-
ing process. DNR was dissolved in 100 mL of the 
ethanol under stirring conditions at room tempera-
ture. PVA solution was prepared in 100 mL of the 
distilled water preheated at 80°C. Prepared solutions 
were combined together and then used as a feed solu-
tion for the spray drying process in Büchi Mini Spray 
Dryer B-290 (Büchi Labortechnik AG, Switzerland) 
with 1.4 mm nozzle. The process parameters were set 
as follows: inlet temperature 75°C, atomization air 






















Table 1. PVA:DNR weight ratios, atomization air flowrates and 















PS 1 1:1 4.84 
3.7 
PS 2 1:1 2.92 
PS 3 1:1 1.85 
PS 4 1:1 1.22 
PS 5 2:1 4.84 
4.8 
PS 6 2:1 2.92 
PS 7 2:1 1.85 
PS 8 2:1 1.22 
PS 9 3:1 4.84 
6.4 
PS 10 3:1 2.92 
PS 11 3:1 1.85 
PS 12 3:1 1.22 
 
 
SCANNING ELECTRON MICROSCOPY 
 The morphology of the microcapsules was exam-
ined by scanning electron microscopy (SEM; 
VEGA3, TESCAN, Czech Republic). The samples 
were fixed to the holder, placed in the Quorum 
SC7620 sputter coater and coated with a thin layer of 
gold and palladium in an inert argon atmosphere and 
a 10
-2
 mbar vacuum. The SEM was operated at an 
acceleration voltage of 5-10 kV. 
 
 
EQUILIBRIUM MOISTURE CONTENT 
 The equilibrium moisture content was determined 
using infrared moisture analyzer Kern MLS 50-3C 
(KERN, Balingen, Germany). Drying was carried out 
at 75 °C and the equilibrium moisture content was 
calculated from Equation 1. 
 












IN VITRO DRUG RELEASE 
 The microcapsules were filled into standard gela-
tin capsules, size 00, before in vitro studies. The 
weight of microcapsules was calculated according to 
the ration of DNR and PVA so that each gelatin cap-
sule would contain approximately the same amount 
of DNR (42.75 mg). The release profiles of DNR 
were determined using the European Pharmacopeia 
method-II dissolution apparatus [9] (RC-6D, Zheng-
zhou Nanbei Instrument, China). Food & Drug Ad-
ministration (FDA) method defined for referent drug 
MULTAQ
® 
(dronedarone hydrochloride tablets) [10] 
was used for in vitro tests of prepared microcapsules. 
Each experiment was carried out in triplicate, using 
1000 mL of a phosphate buffer with pH 4.5, at a 
temperature of 37 ± 0.5 °C. The paddle rotational 
speed was 75 rpm. The gelatin capsules were placed 
into Japanese sinkers, which were placed into the 
beakers. Sampling was performed over a 24h period. 
The samples were filtered using Chromafil Xtra H-
PTFE-20/25 with a pore size of 0.45 μm and subse-
quently analyzed using a UV/Vis spectrophotometer 
(UV-1280, Shimadzu, Japan) to determine the con-
centration by monitoring the absorbance of the DNR 
at 289 nm. 
 
DISSOLUTION KINETICS 
The DDSolver was used for the fitting of the dissolu-
tion profile. Various mathematical models of the drug 
dissolution are already integrated into the DDSolver 
[11]. In this study, the applicability of different mod-
els was tested and the value of R
2
 was used as model 
selection criteria. The release profiles are described 
by the Weibull model (Eq 2). Where, Mt is the 
amount of drug dissolved as a function of time and 
M0 is total amount of drug being released. Parameters 














RESULTS AND DISCUSSION 
 The objective of this research was to obtained 
microcapsules of dronedarone hydrochloride to in-
vestigate the possibility of drug release control by 
using PVA as coating polymer. Microcapsules of 
different DNR:PVA ratios were successfully pre-
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pared. Microencapsulation was performed by spray 
drying at four different atomization air flowrates. In 
addition, the PVA and DNR mass ratios (1:1, 2:1 and 
3:1) were changed which resulted in a total of 12 ex-
periments. Samples are labeled from PS1 to PS12, 
and the corresponding mass ratios and flowrates are 
given in Table 1. Samples PS4, PS8 and PS12 were 







. The efficacy in experiments PS4, PS8 and PS12 
was extremely low due to the huge remaining of the 
samples at the cyclone walls. This could be explained 
by low atomization flowrates that produce large 
droplets which, due to their size, do not completely 
dry at 75°C.  Those samples were not used in in vitro 
study due to the low yield.    
 The efficiency of microencapsulation, the mor-
phology of the obtained microcapsules, as well as the 
equilibrium moisture content of the samples were 
examined. Table 2 shows the efficiency of microen-
capsulation expressed by the ratio of DNR weight in 
samples before and after drying. In addition, in Table 
2 the values of equilibrium moisture content in ob-




Table 2. Microencapsulation efficiency and equilibrium moisture content 














Mass of DNR 







PS1 1:1 4.84 2.0 0.773 77.3 6.4 
PS2 1:1 2.92 2.0 0.647 64.7 7.5 
PS3 1:1 1.85 2.0 0.295 29.5 6.4 
PS5 2:1 4.84 3.0 0.773 77.3 7.5 
PS6 2:1 2.92 3.0 0.677 67.7 8.7 
PS7 2:1 1.85 3.0 0.614 61.4 8.7 
PS9 3:1 4.84 4.0 0.542 54.2 8.7 
PS10 3:1 2.92 4.0 0.524 52.4 9.9 




 Process efficiency increases with the increase of 
the atomization flowrate for samples with the same 
ratio of polymer and the active ingredient (1:1) (PS1, 
PS2, PS3; Table 2). On the other hand, smaller dif-
ferences in the dependence of efficiency on the atom-
ization flowrate were observed for the ratio 2:1 (sam-
ples PS5, PS6 and PS7). The effect of the atomiza-
tion flowrate is insignificant for microcapsules with 
the highest polymer content (3:1) (samples PS9, 
PS10 and PS11) where the values of efficiency are 
similar in all three experiments. Increase of the mi-
croencapsulation efficiency can be explained through 
the atomization step and droplet size. Higher atomi-
zation flowrate results in droplets of smaller sizes 
[12] resulting in faster drying at low temperatures. 
Smaller particles will have enough time to complete 
the drying process before reaching the cyclone 
chamber. An increase in the polymer content leads to 
an increase in the viscosity of the solution, thereby 
reducing the microencapsulation efficiency for the 
samples PS9, PS10 and PS11. The formation of drop-
lets is more influenced by viscosity than the atomiza-
tion air flowrate [13]. Solution with higher viscosity 
will give larger droplets, which is directly related to 
the drying process and microencapsulation efficiency 
[14]. Dried microcapsules were tested for equilibrium 
moisture content at 75°C and the values are present 
in Table 2. Increased equilibrium moisture content 
was observed for samples with higher polymer con-
tent, which is consistent with previously described 
droplet size and drying conditions. The equilibrium 
moisture content of all samples is less than 10 %. 
 The samples were characterized by a scanning 
electron microscope (SEM) to determine their mor-
phology. The micrographs are shown in Figures 1-4. 
 
 Figure 1 shows micrographs of the sample PS1 
corresponding to an equal ratio of PVA and DNR and 
maximum atomization flowrate. The microcapsules 
are very small and due to their size agglomeration 
problem occurred.  
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Figure 1. SEM micrographs of the sample PS1; a) 1000x, b) 2000x 
 
 
Figure 2. SEM micrographs of the sample PS5; a) 1000x, b) 2000x 
 
 
 Figure 2 shows micrographs of a PS5 sample 
containing polymer and an active ingredient in the 
ratio of 2:1. Both solutions (PS1 and PS5) where 
dried at maximal atomization flowrate resulting in 
small microcapsules. Same results were obtained for 





Figure 3. SEM micographs of the sample PS9; a) 1000x b) 2000x 
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 On the other hand, if one compares polymer con-
tent in samples PS1 (1:1), PS5 (2:1) and PS9 (3:1) it 
can be seen from SEM micrographs that particle size 
increases, which is in accordance with the efficiency 
and equilibrium moisture content. Increasing the vis-
cosity of the solution causes the formation of larger 








 Figures 3 and 4 show micrographs of obtained 
microcapsules in which the PVA:DNR ratio is 3:1. 
The influence of different atomization air flowrate is 
considered. By reducing the flowrate of atomization 
air, a significant increase in particle size was seen. 
These samples clearly show spherical shape of mi-
crocapsules. 
 
 In vitro drug release profiles of DNR are present-





Figure 5. Dissolution profiles for different polymer content at atomization air flowrate 4.84 x 10-4 m3 s-1 
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 The release profiles for the same atomization 
flowrate with different PVA and DNR ratios were 
compared. Increase in polymer content results in a 
prolonged release of DNR over 24h period. 
 Figures 8-10 provide comparisons of the in vitro 
release profiles for the samples obtained with spray 
drying at a different atomization air flowrate and 
equal PVA and DNR ratios.  
 Samples PS1, PS2 and PS3 have almost the same 
release profiles. In samples with equal PVA and 
DNR ratio, a large amount of DNR is released very 
quickly and its maximum is reached after 90 minutes. 
Independent of the atomization air flowrate, all sam-
ples with equal PVA and DNR ratios have the same 
release profile. This is explained by insufficient 
amount of polymer to form a shell around the DNR. 
The differences in the release profiles are more pro-
nounced for different atomization flowrates by in-
creasing the polymer content (Fig. 10 and 11). 
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Figure 8. Dissolution profiles for different atomization air flowrate at same polymer content 
 
 
Figure 9. Dissolution profiles for different atomization air flowrate at same polymer content 
 
 
Figure 10. Dissolution profiles for different atomization air flowrate at same polymer content 
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 The release kinetics of the active ingredient was 
described by the Weibull model (Eq. 2), which was 
selected based on the high R
2
 values. The Weibull 
model is often used for comparison of the release 
profiles of an active ingredient from matrix dosage 
form [15]. Table 3 shows the parameter values of the 
selected kinetic model. 
 






PS1 5.218 0.666 0.994 
PS2 9.572 0.754 0.989 
PS3 2.880 0.536 0.994 
PS5 21.279 0.622 0.972 
PS6 32.009 0.805 0.994 
PS7 11.756 0.650 0.988 
PS9 656.62 1.021 0.986 
PS10 1277.7 1.144 0.994 
PS11 29.185 0.706 0.971 
 
 Parameter b is related to the curve type. When the 
value of parameter b is less than 1, curve is parabolic 
with high initial slope and a consistent exponential 
character. That corresponds to the rapid release of a 
large amount of the active ingredient from the dosage 
form. When b is greater than 1, curve is sigmoidal 
with inflection point. Such curves indicate slower 
drug release [16]. Samples with the highest polymer 
content (3:1) (PS9, PS10 and PS11) show the highest 
values of parameter b, as expected, since the increase 
of polymer content will prolong  drug release. Pa-
rameter a defines the release process timescale [16]. 
Higher values of this parameter indicate longer pro-
cess time, which is, in this case, prolonged drug re-
lease. The highest values were observed for the sam-
ples with PVA and DNR ratio of 3:1, which was con-
firmed by parameter b. The only discrepancy was 
observed for sample PS11. We can attribute this to 
the lowest R
2
 value and inadequate model fit for ob-




 Microcapsules of dronedarone hydrochloride 
coated with poly(vinyl alcohol), with different poly-
mer content and different process conditions of spray 
drying, were prepared. Selected process conditions 
(polymer content and atomization air flowrate) affect 
the rate of the drug release. Atomization air flowrate 
has direct influence on the microcapsules size, where 
smaller microcapsules were obtained by increasing 
the atomization air flowrate. The microencapsulation 
efficiency is greater than 50% for all samples. SEM 
micrographs confirmed that the finer particles were 
obtained at a higher atomization air flowrate. In addi-
tion, by increasing the polymer content, the larger 
particles were obtained. Microcapsules with the 
highest polymer content showed the prolonged re-
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